Tags

Type your tag names separated by a space and hit enter

Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function.
Hepatogastroenterology. 1998 Sep-Oct; 45(23):1726-30.H

Abstract

BACKGROUND/AIMS

The aim of this study was to investigate the long term effect of prophylactic endoscopic injection sclerotherapy (EIS) on liver function.

METHODOLOGY

This study was a retrospective investigation of seventy-eight patients with liver cirrhosis, whose liver function was classified as Child's A before follow-up. Laboratory data were retrospectively examined before and after follow-up, and a comparison was made between the EIS group (n=21) and the non-treated group (n=57).

RESULTS

In the 3 or more years of follow-up, cholinesterase and total cholesterol levels deteriorated in several severe-variceal cases. However, these levels did not deteriorate over the 3 or more years of follow-up in the EIS group.

CONCLUSION

Prophylactic endoscopic injection sclerotherapy among patients with early stage LC may prevent the deterioration of liver function.

Authors+Show Affiliations

The First Department of Internal Medicine, Mie University School of Medicine, Tsu. atarum@clin medic.mie-u.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9840136

Citation

Murata, K, et al. "Long-term Effect of Prophylactic Endoscopic Injection Sclerotherapy On Liver Function." Hepato-gastroenterology, vol. 45, no. 23, 1998, pp. 1726-30.
Murata K, Sugimoto K, Okuda K, et al. Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function. Hepatogastroenterology. 1998;45(23):1726-30.
Murata, K., Sugimoto, K., Okuda, K., Shimizu, A., Takase, K., Nakano, T., & Tameda, Y. (1998). Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function. Hepato-gastroenterology, 45(23), 1726-30.
Murata K, et al. Long-term Effect of Prophylactic Endoscopic Injection Sclerotherapy On Liver Function. Hepatogastroenterology. 1998 Sep-Oct;45(23):1726-30. PubMed PMID: 9840136.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function. AU - Murata,K, AU - Sugimoto,K, AU - Okuda,K, AU - Shimizu,A, AU - Takase,K, AU - Nakano,T, AU - Tameda,Y, PY - 1998/12/5/pubmed PY - 1998/12/5/medline PY - 1998/12/5/entrez SP - 1726 EP - 30 JF - Hepato-gastroenterology JO - Hepatogastroenterology VL - 45 IS - 23 N2 - BACKGROUND/AIMS: The aim of this study was to investigate the long term effect of prophylactic endoscopic injection sclerotherapy (EIS) on liver function. METHODOLOGY: This study was a retrospective investigation of seventy-eight patients with liver cirrhosis, whose liver function was classified as Child's A before follow-up. Laboratory data were retrospectively examined before and after follow-up, and a comparison was made between the EIS group (n=21) and the non-treated group (n=57). RESULTS: In the 3 or more years of follow-up, cholinesterase and total cholesterol levels deteriorated in several severe-variceal cases. However, these levels did not deteriorate over the 3 or more years of follow-up in the EIS group. CONCLUSION: Prophylactic endoscopic injection sclerotherapy among patients with early stage LC may prevent the deterioration of liver function. SN - 0172-6390 UR - https://www.unboundmedicine.com/medline/citation/9840136/Long_term_effect_of_prophylactic_endoscopic_injection_sclerotherapy_on_liver_function_ L2 - https://medlineplus.gov/gastrointestinalbleeding.html DB - PRIME DP - Unbound Medicine ER -